Medartis Holding AG Stock

Equities

MED

CH0386200239

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:31:23 2024-04-17 am EDT 5-day change 1st Jan Change
81.2 CHF -0.37% Intraday chart for Medartis Holding AG -1.22% -3.33%
Sales 2024 * 247M 271M Sales 2025 * 287M 315M Capitalization 1.1B 1.21B
Net income 2024 * 7M 7.69M Net income 2025 * 15M 16.47M EV / Sales 2024 * 4.56 x
Net Debt 2024 * 22.74M 24.97M Net Debt 2025 * 16.66M 18.3M EV / Sales 2025 * 3.9 x
P/E ratio 2024 *
130 x
P/E ratio 2025 *
64.2 x
Employees 812
Yield 2024 *
-
Yield 2025 *
-
Free-Float 40.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.37%
1 week-1.22%
Current month-9.17%
1 month+4.37%
3 months+13.25%
6 months+3.84%
Current year-3.33%
More quotes
1 week
81.00
Extreme 81
82.00
1 month
77.00
Extreme 77
90.00
Current year
67.10
Extreme 67.1
90.00
1 year
63.50
Extreme 63.5
99.40
3 years
60.40
Extreme 60.4
148.40
5 years
31.60
Extreme 31.6
148.40
10 years
31.60
Extreme 31.6
148.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 19-08-31
Director of Finance/CFO 56 21-02-28
Chief Operating Officer - 21-12-31
Members of the board TitleAgeSince
Founder 61 97-11-02
Director/Board Member 55 17-12-31
Chairman 61 20-04-16
More insiders
Date Price Change Volume
24-04-17 81.2 -0.37% 2,077
24-04-16 81.5 +0.62% 3,898
24-04-15 81 0.00% 476
24-04-12 81 0.00% 1,433
24-04-11 81 -1.46% 2,464

Delayed Quote Swiss Exchange, April 17, 2024 at 11:31 am EDT

More quotes
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
81.2 CHF
Average target price
103.5 CHF
Spread / Average Target
+27.46%
Consensus